Literature DB >> 18481738

Invisible and visible symptoms of multiple sclerosis: which are more predictive of health distress?

Carmel Parker White1, Mark B White, Candyce S Russell.   

Abstract

The purpose of this study was to examine whether it is the invisible or the visible symptoms or signs of multiple sclerosis (MS) that are associated with greater health distress. Visible symptoms include the use of assistive devices, problems with balance, and speech difficulties, while invisible symptoms include fatigue, pain, depression, and anxiety. In a sample of 145 adults with MS, participants reported on these symptoms and their current level of self-reported health distress. Hierarchical regression analyses were used to determine whether invisible or visible symptoms were more predictive of health distress. When visible symptoms were added as the first step in the regression, 18% of the variance in health distress was explained. When invisible symptoms were added as the first step, 53% of the variance was accounted for. The invisible symptoms of pain and depression were the most significant predictors of distress. For a subset of the sample that had had MS for more than 11 years, pain and depression continued to be important predictors, but assistive-device use and fatigue were also important. Nurses should be aware that invisible symptoms may be more troubling to patients than visible symptoms and should ensure that adequate screening and treatment are provided for those with MS.

Entities:  

Mesh:

Year:  2008        PMID: 18481738     DOI: 10.1097/01376517-200804000-00007

Source DB:  PubMed          Journal:  J Neurosci Nurs        ISSN: 0888-0395            Impact factor:   1.230


  17 in total

Review 1.  Communication and aging.

Authors:  Kathryn M Yorkston; Michelle S Bourgeois; Carolyn R Baylor
Journal:  Phys Med Rehabil Clin N Am       Date:  2010-05       Impact factor: 1.784

2.  Pain affects depression through anxiety, fatigue, and sleep in multiple sclerosis.

Authors:  Dagmar Amtmann; Robert L Askew; Jiseon Kim; Hyewon Chung; Dawn M Ehde; Charles H Bombardier; George H Kraft; Salene M Jones; Kurt L Johnson
Journal:  Rehabil Psychol       Date:  2015-01-19

3.  Effect of Multiple Sclerosis on Daily Activities, Emotional Well-being, and Relationships: The Global vsMS Survey.

Authors:  Ann D Bass; Bart Van Wijmeersch; Lori Mayer; Mathias Mäurer; Aaron Boster; Matt Mandel; Colin Mitchell; Kersten Sharrock; Barry Singer
Journal:  Int J MS Care       Date:  2019-08-28

4.  Multi-centre parallel arm randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based cognitive behavioural approach to managing fatigue in people with multiple sclerosis.

Authors:  Peter W Thomas; Sarah Thomas; Paula Kersten; Rosemary Jones; Alison Nock; Vicky Slingsby; Colin Green; Roger Baker; Kate Galvin; Charles Hillier
Journal:  BMC Neurol       Date:  2010-06-16       Impact factor: 2.474

5.  The use of focus groups to characterize symptoms in persons with multiple sclerosis.

Authors:  Pamela K Newland; Florian P Thomas; Marguerite Riley; Louise H Flick; Arleen Fearing
Journal:  J Neurosci Nurs       Date:  2012-12       Impact factor: 1.230

6.  Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis.

Authors:  Dagmar Amtmann; Jiseon Kim; Hyewon Chung; Alyssa M Bamer; Robert L Askew; Salene Wu; Karon F Cook; Kurt L Johnson
Journal:  Rehabil Psychol       Date:  2014-03-24

7.  Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosis.

Authors:  Emily J Hadgkiss; George A Jelinek; Tracey J Weiland; Greg Rumbold; Claire A Mackinlay; Siegfried Gutbrod; Ian Gawler
Journal:  Neurol Sci       Date:  2012-02-25       Impact factor: 3.307

8.  Exploring strategies used following a group-based fatigue management programme for people with multiple sclerosis (FACETS) via the Fatigue Management Strategies Questionnaire (FMSQ).

Authors:  S Thomas; P Kersten; P W Thomas; V Slingsby; A Nock; R Jones; A Davies Smith; K T Galvin; R Baker; C Hillier
Journal:  BMJ Open       Date:  2015-10-20       Impact factor: 2.692

9.  Cognitive impairment and "invisible symptoms" are not associated with CCSVI in MS.

Authors:  Carmela Leone; Emanuele D'Amico; Sabina Cilia; Alessandra Nicoletti; Luigi Di Pino; Francesco Patti
Journal:  BMC Neurol       Date:  2013-07-27       Impact factor: 2.474

10.  Psychosocial and Medical Determinants of Health-related Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis.

Authors:  Isaac Rahimian Boogar; Siavash Talepasand; Mohammad Jabari
Journal:  Noro Psikiyatr Ars       Date:  2018-03-19       Impact factor: 1.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.